<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________
SCHEDULE 13D
(RULE 13d-101)
UNDER THE SECURITIES EXCHANGE ACT OF 1934
INFORMATION TO BE INCLUDED IN THE STATEMENTS FILED PURSUANT TO
RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
Mecon, Inc.
- -------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- -------------------------------------------------------------------------------
(Title of Class of Securities)
58400M-10-5
-------------------------------------------------
(CUSIP Number)
Tamara L. Thompson, Venture Law Group, 2800 Sand Hill Road, Menlo Park,
California 94025
- -------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
August 1, 1997
-------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box X .
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 6 Pages
<PAGE>
SCHEDULE 13D
- ---------------------- ------------------
CUSIP NO. 58400M-10-5 PAGE 2 OF 6 PAGES
- ---------------------- ------------------
- -----------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
VASU R. DEVAN
SSN: ###-##-####
LATHA DEVAN
SSN: ###-##-####
- -----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) /x/
(b) / /
- -----------------------------------------------------------------------------
3 SEC USE ONLY
- -----------------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
- -----------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) / /
- -----------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES
- -----------------------------------------------------------------------------
7 SOLE VOTING POWER
NOT APPLICABLE
NUMBER OF -------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY 1,153,380
OWNED BY -------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING NOT APPLICABLE
PERSON -------------------------------------------------------------
WITH 10 SHARED DISPOSITIVE POWER
1,153,380
- -----------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED
1,153,380
- -----------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES / /
NOT APPLICABLE
- -----------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
18.79%
- -----------------------------------------------------------------------------
14 TYPE OF REPORTING PERSONS
IN
- -----------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
- ---------------------- ------------------
CUSIP NO. 58400M-10-5 PAGE 3 OF 6 PAGES
- ---------------------- ------------------
ITEM 1 - SECURITY AND ISSUER
MECON, Inc. ("Mecon" or the "Issuer") provides subscriptions to an
information database, licenses to software products, and consulting services to
the heath care industry. These products and services improve performance and
reduce costs for health care organizations through the use of benchmark
information, processes, and tools.
This statement relates to the Common Stock of Mecon, $.001 par value
("Common Stock"). The 1,153,380 shares of Common Stock held by the Devan Family
Trust and beneficially owned by Vasu R. Devan and Latha Devan (the "Reporting
Persons") referred to in this statement are referred to as "Shares". The
principal executive offices of Mecon are located at 200 Porter Drive, Suite 100,
San Ramon, California 94593.
ITEM 2 - IDENTITY AND BACKGROUND
(a) Name:
1. Vasu R. Devan
2. Latha Devan
Collectively, these persons are referred to herein as the "Reporting
Persons."
(b) Residence or business address: 200 Porter Drive, Suite 100, San
Ramon, CA 94583
(c) Present principal employment:
1. Vasu R. Devan, Chairman of the Board, President and Chief
Executive Officer of Mecon.
2. Latha Devan - none.
(d) Criminal convictions: None
(e) Civil proceedings: None
(f) Citizenship: United States
ITEM 3 - SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
[STATE THE SOURCE (E.G. THE TRUST) AND AMOUNT OF FUNDS USED TO MAKE THE
PURCHASE____________________].
<PAGE>
SCHEDULE 13D
- ---------------------- ------------------
CUSIP NO. 58400M-10-5 PAGE 4 OF 6 PAGES
- ---------------------- ------------------
ITEM 4 - PURPOSE OF TRANSACTION
The Reporting Persons acquired the Shares to be held in the name of [a
trust formed by them, called] the Devan Family Trust for the purpose of making
an investment in the Issuer and not with the present intention of acquiring
control of the Issuer's business.
The Reporting Persons from time to time intend to review the investment in
the Issuer on the basis of various factors, including the Issuer's business,
financial condition, results of operations and prospects, general economic and
industry conditions, the securities markets in general and those for the
Issuer's securities in particular, as well as other developments and other
investment opportunities. Based upon such review, the Reporting Persons may
take such actions in the future as the Reporting Persons may deem appropriate in
light of the circumstances existing from time to time. If the Reporting Persons
believe that further investment in the Issuer is attractive, whether because of
the market price of the Issuer's securities or otherwise, the Reporting Persons
may acquire Common Stock of the Issuer either in the open market or in privately
negotiated transactions. Similarly, depending on market and other factors, the
Reporting Persons may determine to dispose of some or all of the Shares
currently owned or otherwise acquired either in the open market or in privately
negotiated transactions.
The Reporting Persons have not formulated any plans or proposals which
relate to or would result in: (a) the acquisition by any person of additional
securities of the Issuer or the disposition of securities of the Issuer, (b) an
extraordinary corporate transaction involving the Issuer or, (c) a sale or
transfer of a material amount of assets of the Issuer, (d) any change in the
present board of directors or management of the Issuer, (c) any material change
in the Issuer's capitalization or dividend policy, (f) any other material change
in the Issuer's business or corporate structure, (g) changes in the Issuer's
certificate of incorporation or bylaws or instruments corresponding thereto or
other actions which may impede the acquisition or control of the Issuer by any
person, (h) causing a class of the Issuer's securities to be deregistered or
delisted, (i) a class of equity securities of the Issuer becoming eligible for
termination of registration or (j) any action similar to any of those enumerated
above.
ITEM 5 - INTEREST IN SECURITIES OF THE ISSUER
(a) As of the date of this statement, the Reporting Persons beneficially
owned 1,153,380 shares of Common Stock, which represent a beneficial ownership
of approximately 18.79% of the Issuer's outstanding Common Stock based on
6,138,500 shares outstanding as of February 3, 1998 at the time the Issuer's
last Form 10-QSB was filed.
(b) The Reporting Persons have sole power to vote and to direct the vote
of, and sole power to dispose or to direct the disposition of, all 1,153,380
shares of Common Stock beneficially owned on the date of this statement.
<PAGE>
SCHEDULE 13D
- ---------------------- ------------------
CUSIP NO. 58400M-10-5 PAGE 5 OF 6 PAGES
- ---------------------- ------------------
(c) The Reporting Persons have effected the following transactions in the
Issuer's Common Stock: on July 30, 1997, the Reporting Persons acquired 10,000
shares of Common Stock in the open market at $4.3750 per share; on July 31,
1997, the Reporting Persons acquired 3,400 shares of Common Stock in the open
market at $4.3750 per share; on August 1, 1997, the Reporting Persons acquired
1,600 shares of Common Stock in the open market at $4.3750 per share; on
February 26, 1998, the Reporting Persons disposed of 35,000 shares of Common
Stock in the open market at $8.6250 per share and on February 27, 1998, the
Reporting Persons disposed of 13,000 shares of Common Stock in the open market
at $8.6250 per share.
(d) No other person is known to the Reporting Persons to have the right to
receive or the power to direct the receipt of dividends from, or proceeds from
the sale of, any Common Stock beneficially owned by the Reporting Persons on the
date of this statement.
(e) Not applicable.
ITEM 6 - CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER
Vasu R. Devan is the Chairman of the Board, President and Chief Executive
Officer of Mecon. Mr. Devan has an employment agreement dated September 9, 1994
with the Issuer. Latha Devan is married to Mr. Devan.
ITEM 7 - MATERIAL TO BE FILED AS EXHIBITS
None.
<PAGE>
SCHEDULE 13D
- ---------------------- ------------------
CUSIP NO. 58400M-10-5 PAGE 6 OF 6 PAGES
- ---------------------- ------------------
SIGNATURE
After reasonable inquiry and to the best of our knowledge and belief, we
certify that the information set forth in this statement is true, complete and
correct.
Date: April 18, 1998 /s/ Vasu Devan
-----------------------
Vasu R. Devan
/s/ Latha Devan
-----------------------
Latha Devan
The original statement shall be signed by each person on whose behalf the
statement is filed or his or her authorized representative. If the statement is
signed on behalf of a person by his or her authorized representative (other than
an executive officer or general partner of this filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Securities and Exchange Commission may be
incorporated by reference. The name and any title of each person who signs the
statement shall be typed or printed beneath his or her signature.
ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL
CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001)
